Omecamtiv Mecarbil Withdrawn Phase 3 Trials for Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT04464525Omecamtiv Mecarbil Post-trial Access Study